PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25485645-0	2015	The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists.	Varenicline	15-26	5-hydroxytryptamine receptor 3A	Homo sapiens	106-112	
25485645-3	2015	Varenicline, a nonselective neuronal nicotinic receptor (NNR) agonist and full agonist of 5-HT3A receptors, helps reduce smoking among schizophrenic patients.	Varenicline	0-11	5-hydroxytryptamine receptor 3A	Homo sapiens	90-96	
25485645-8	2015	Collectively, these results indicate that varenicline at low-to-moderate doses may be beneficial against impaired sensory gating in schizophrenia; however, higher doses may induce anxiogenic effects, which can be prevented with antagonists of NNRs or 5-HT3A receptors.	Varenicline	42-53	5-hydroxytryptamine receptor 3A	Homo sapiens	251-257